LATEST NEWS
More
Roche’s Perjeta Regimen Helped People with HER2-positive Early Breast Cancer Live...
Roche’s Perjeta regimen helped people with HER2-positive early breast cancer live longer without their disease returning or getting worse compared to Herceptin and chemotherapy...
Re-irradiation of adenoid cystic carcinoma: Analysis and evaluation of outcome in...
Local relapse in head and neck cancer is a very difficult therapeutic situation. Chemotherapy rarely produces durable tumour control; therefore surgery as a potentially...
SPECIALITTY AREAS
- All
- ASCO 2016
- Ash 2014
- brain tumor
- Breast cancer
- Cancer
- Chemotherapy
- CLL
- Conferences
- ECCO 2017
- Embedded Technology
- EONS 10
- ESMO
- Featured
- Imaging Technology
- Leukaemia
- Lung cancer
- Media
- Medical Devices
- Melanoma
- Metastatic
- Neutropenia
- Oncology
- Oncology Nursing
- Oropharyngeal cancer
- Ovarian cancer
- Pharmacy
- Prevention
- Prostate cancer
- Public Health
- Radio therapy
- Rare Tumors
- Rectal Cancer
- Research
- Sarcoma
- Specialities
- T cell
- Thyroid cancer
- vaccine
- Videos
- Viruses & Bacteria
- Wireless Technology
More
LATEST ARTICLES
- Advertisement -
